ストックスクリーナーアプリを入手
29.70
2.63%
-0.90
前日終値:
$30.60
開ける：
$30.64
24時間の取引高:
65,547
Relative Volume:
0.80
時価総額：
$316.32M
収益：
$96.10M
当期純損益:
$-31.96M
株価収益率:
-7.3758
EPS:
-4.0267
ネットキャッシュフロー:
$-25.27M
1週間 パフォーマンス:
+23.99%
1か月 パフォーマンス:
+34.09%
6か月 パフォーマンス:
+94.36%
1年 パフォーマンス:
+216.97%
1日の値動き範囲:
$29.11
$31.06
1週間の範囲:
$23.95
$31.31
52週間の値動き範囲:
$5.26
$31.31
Biodesix Inc Stock (BDSX) Company Profile
Compare BDSX vs TMO, DHR, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
29.98 | 253.54M | 96.10M | -31.96M | -25.27M | -4.0267 |
TMO
Thermo Fisher Scientific Inc
|
633.54 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
217.51 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.84 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
158.03 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
264.02 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-07-26 | 開始されました | Craig Hallum | Buy |
| 2024-05-13 | 開始されました | TD Cowen | Buy |
| 2024-05-03 | 開始されました | Lake Street | Buy |
| 2021-11-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 開始されました | BTIG Research | Buy |
| 2020-11-23 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-23 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-23 | 開始されました | William Blair | Outperform |
すべてを表示
Biodesix Inc (BDSX) 最新ニュース
Biodesix (BDSX) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison on the Day; After Earnings: The Stock Loses 5.91% in the Latest SessionCEO Earnings Statement - vinanet.vn
Biodesix (BDSX) Results Check: The Bottom-Line Figure Beats Its Comparison; After Earnings: The Market Price Declines 3.91% in Latest TradingGuidance Accuracy Score - Vinanet
46,989 Shares in Biodesix, Inc. $BDSX Purchased by GSA Capital Partners LLP - MarketBeat
AIGH Capital Management LLC Acquires New Stake in Biodesix, Inc. $BDSX - MarketBeat
Biodesix (BDSX) Edges Higher at $24.0 as Bulls Defend Key SupportVol Target Rebalance - vinanet.vn
Walleye Capital LLC Makes New $1.68 Million Investment in Biodesix, Inc. $BDSX - MarketBeat
Sei Investments Co. Makes New Investment in Biodesix, Inc. $BDSX - MarketBeat
Biodesix Stock Price Forecast. Should You Buy BDSX? - StockInvest.us
BDSX Q2 2026 Earnings: EPS Beats Estimates by 22.85% as Loss NarrowsEarnings Preview - vinanet.vn
Biodesix director Jack Schuler buys company stock, valued at $366,991 By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys company stock, valued at $366,991 - Investing.com
BDSX Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares Dip 1.78Earnings Yield Spread - Vinanet
Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 15,000 Shares of Stock - MarketBeat
Biodesix Insider Bought Shares Worth $366,992, According to a Recent SEC Filing - marketscreener.com
Biodesix Inc (BDSX) major holder Jack W. Schuler buys 15,000 shares - Stock Titan
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Biodesix director Jack Schuler buys $665,940 in company stock By Investing.com - Investing.com Australia
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 13,700 Shares of Stock - MarketBeat
Insider Buying: Biodesix (NASDAQ:BDSX) Director Purchases 13,900 Shares - MarketBeat
Biodesix director Jack Schuler buys $665,940 in company stock - Investing.com
Biodesix at Canaccord Genuity conference: growth, margins in focus By Investing.com - Investing.com Nigeria
Biodesix (BDSX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Biodesix (BDSX) major holder Jack W. Schuler adds shares via trusts - Stock Titan
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference - TradingView
Biodesix 10% owner Jack W. Schuler reports $669,537 common share purchase - Bitget
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Canaccord raises Biodesix stock price target on strong test volume By Investing.com - Investing.com India
Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet - Yahoo Finance
BDSX Maintained by Canaccord Genuity -- Price Target Raised to $35 - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Canaccord raises Biodesix stock price target on strong test volume - Investing.com India
HC Wainwright Forecasts Biodesix's Q3 Earnings (NASDAQ:BDSX) - MarketBeat
Earnings Update: Here's Why Analysts Just Lifted Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$32.67 - webull.com
H.C. Wainwright Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Biodesix Inc (BDSX) Stock News Today - TradingKey
Biodesix boosts sales, trims loss as diagnostics firm pushes toward profitability - BizWest
A Quick Look at Today's Ratings for Biodesix(BDSX.US), With a Forecast Between $27 to $40 - Moomoo
Biodesix (BDSX) Stock Pullback Puts Focus On Losses Despite Stronger Margins - Sahm
BDSX Maintains Buy Rating -- Price Target Raised to $27.00 by HC Wainwright - GuruFocus
Biodesix, Inc. Stock 12‑Month Price Target Raised to $32.67, Implies 43% Upside - TradingView
Biodesix, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
William Blair Initiates Biodesix(BDSX.US) With Buy Rating - Moomoo
CCORF Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Earnings call transcript: Biodesix tops revenue forecast in Q2 2026, shares fall after hours - Investing.com Nigeria
Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic Testing Growth - GuruFocus
Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic ... - Yahoo Finance
Is Biodesix Inc (BDSX) Overvalued After Q2 2026 Earnings Beat? G - GuruFocus
Biodesix Q2 Earnings Call Highlights - MarketBeat
Biodesix (NASDAQ:BDSX) Announces Earnings Results - MarketBeat
Biodesix Q2 2026 earnings: Diagnostic testing growth narrows losses - TradingKey
Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Biodesix Inc (BDSX) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
0.52%
大文字化:
|
ボリューム (24 時間):